Columbia named Dr. Sadelain director of the Cancer Cell Therapy Initiative at the Herbert Irving Comprehensive Cancer Center and the first director of the new Columbia Initiative in Cell Engineering and Therapy, according to a Sept. 30 news release from Columbia.
Dr. Sadelain founded the Center for Cell Engineering at Memorial Sloan Kettering in 2007, where he led the development of CAR-T cells to target specific markers found in certain blood cancer cells.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
